MGB Eclipse Probe Detection of Category A Organisms

Information

  • Research Project
  • 6689127
  • ApplicationId
    6689127
  • Core Project Number
    R43AI052905
  • Full Project Number
    1R43AI052905-01A1
  • Serial Number
    52905
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2003 - 22 years ago
  • Project End Date
    12/31/2003 - 22 years ago
  • Program Officer Name
    BEANAN, MAUREEN J.
  • Budget Start Date
    7/15/2003 - 22 years ago
  • Budget End Date
    12/31/2003 - 22 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    7/15/2003 - 22 years ago
Organizations

MGB Eclipse Probe Detection of Category A Organisms

DESCRIPTION (provided by investigator): Fluorogenic minor groove binder (MGB) probes containing an MGB-quencher at the 5'-end and a fluorophore at the 3'-end have been recently reported. These probes fluoresce on hybridization to the complementary targets. The 5'-MGB-quencher group prevents 5' - nuclease digestion by Taq polymerase during homogeneous amplification. The 5'-MGB-quencher-oligonucleotide-fluors can be used as probes in general nucleic acid and SNP detection assays. We propose to use a new software prediction program to develop MGB Eclipse probe assays to detect Clostridium botulinum, Bacillus anthracis and Yersinia pestis. The designed probes and primers will be optimized with use of three modified bases to improve probe performance of AT- and GC-rich sequences. In the Phase 1 effort, we will design and optimize the primers and probes and demonstrate function of the MGB Eclipse probe assays on a set of known target samples. The specificity of the probes will be evaluated against panels of closely related non-pathogenic organisms. In Phase II, we will expand the number of Category A organisms and improve throughput by multiplexing. In addition, commercial prototype MGB Eclipse(TM) probe assays will be developed for each of these organisms.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    EPOCH BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BOTHELL
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    980213906
  • Organization District
    UNITED STATES